📰 Devika Syamnath News
Page 3 - Devika Syamnath News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Devika Syamnath. Real-time updates on events, politics, business and more.
May 16, 2024
The Dow crossed the 40,000 level for the first time on Thursday, notching a fresh all-time high and leading Wall Street gains a day after tepid inflation data bolstered hopes of interest-rate cuts. ...
May 16, 2024
Wall Streets main indexes were poised to open nearly flat on Thursday, a day after hitting all-time highs as tepid consumer inflation data bolstered hopes of interest-rate cuts. All...
May 16, 2024
May 16 - More than half of the oil sands production from Canada could be impacted if the wildfires in Alberta and British Columbia worsen, Rystad Energy said in a report...
May 7, 2024
Duke Energy beat Wall Street estimates for first-quarter profit on Tuesday, as the utility benefited from higher rates and robust demand for electricity. Income from Dukes electric...
May 6, 2024
May 6 - Fewer low-income Americans took out mortgage loans last year than 2020, real estate broker Redfin said in a report on Monday, as steep interest rates make...
May 6, 2024
Tyson Foods surpassed Wall Street expectations for second-quarter profit on Monday, as it begins to reap the benefits of shutting some chicken processing plants to reduce costs. The...
May 6, 2024
Indian generic drugmaker Lupin reported a smaller-than-expected rise in fourth-quarter profit on Monday, as higher raw material costs more than offset strong demand for its drugs in North America...
May 3, 2024
Pipeline operator TC Energy beat first-quarter profit estimates on Friday, helped by high demand. The company posted an adjusted profit of C$1.24 per share for the quarter ended March...
May 3, 2024
Pipeline operator TC Energy beat first-quarter profit estimates on Friday, helped by robust demand for liquefied natural gas . Demand in the U.S., the largest importer of Canadas oil...
May 3, 2024
-U.S. drugmaker Amgens shares jumped 14% premarket on Friday as the company said it was encouraged by interim trial data on its experimental obesity drug, denting rival stocks but... -May 03, 2024 at 06:16 am EDT - MarketScreener